. Author manuscript; available in PMC: 2021 Oct 25.

Published in final edited form as: J Clin Lipidol. 2016 Sep 28;10(6):1389–1396. doi: 10.1016/j.jacl.2016.09.012

Table 3.

Baseline Lp(a) mass and VAP-Lp(a)-C levels in relation to quartiles of baseline HDL levels

	HDL-C (mg/dL) levels by quartiles
	27.0–40.0 (n = 146)	41.0–47.0 (n = 137)	48.0–54.0 (n = 136)	56.0–114.0 (n = 133)	P for trend
Lp(a) mass (mg/dL), median (IQR)	9.9 (5.1–38.6)	12.1 (5.4–49.6)	9.9 (5.1–41.0)	13.6 (6.2–39.9)	.36
VAP-Lp(a)-C (mg/dL), mean (SD)	6.3 (3.1)	7.2 (3.6)	7.5 (3.3)	9.4 (4.2)	<.001
	VAP-HDL-C (mg/dL) levels by quartiles
	29.0–41.0 (n = 137)	42.0–47.0 (n = 140)	48.0–55.0 (n = 135)	56.0–104.0 (n = 140)
Lp(a) mass (mg/dL), median (IQR)	8.9 (4.6–38.0)	11.4 (5.3–37.7)	11.4 (5.8–44.4)	14.2 (6.2–41.4)	.36
VAP-Lp(a)-C (mg/dL), mean (SD)	6.3 (3.1)	6.7 (3.5)	7.7 (3.3)	9.4 (4.2)	<.001

IQR, interquartile range.